Clinical trials: High Blood Lead Level
Elevated Blood Lead Levels
A Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Children
The study is a parallel, randomized, double-blind, placebo controlled clinical trial will evaluate the effect of Lactobacillus plantarum DSM 33464 on reduction of Blood lead levels and general well-being of children.
- Trial name
- NCT04891666
- Testing
- Lactobacillus plantarum DSM 33464
- Where
- 5 sites in China
- Volunteers
- 66 people
- Sponsor
- Novozymes A/S
Elevated Blood Lead Levels
Effect of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Young Women of Child-bearing Age
We hypothesize that Lactobacillus Plantarum DSM 33464 reduce lead levels. Approximately 200 women 18 to 40 will be screened for blood lead levels.
- Trial name
- NCT05507021
- Testing
- Lactobacillus plantarum DSM 33464, MegaMetalliQ
- Where
- Mexico
- Volunteers
- 47 people, healthy volunteers welcome
- Sponsor
- Novozymes A/S
Elevated Blood Lead Levels
Lead Detoxifying Effects of Ascorbic Acid Among School Going Adolescents of Karachi- A Cluster Randomized Control Trial
The toxic nature of lead has been recognized ubiquitous for than 2,000 years and today it is a persistent and common environmental contaminant in most parts of the world.
- Trial name
- LDVC (NCT02745873)
- Testing
- Ascorbic Acid
- Volunteers
- 144 people, healthy volunteers welcome
- Sponsor
- Aga Khan University
Exposure to Toxic Dust, Elevated Blood Lead Levels
Reducing Lead Dust Exposure in Older Housing
The objective of this study is to assess the effectiveness of portable air filtration (PAF) for mitigating lead dust exposures and reducing childhood blood lead levels in older housing.
- Trial name
- NCT07485608
- Testing
- portable air filtration systems
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Michigan State University
Lead Exposure, High Blood Lead Level
Lead Exposure Intervention Program
The goal of this clinical trial is to learn if BLL (blood lead level) screening and "healthy home" lead prevention program created in the US is adaptable to a Sub-Saharan African context.
- Trial name
- LEIP (NCT07401251)
- Testing
- Home visit with tailored messages, In-clinic lead risk reduction intervention
- Where
- Kenya
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- University of Washington